Measurement of viral gene expression (gB and LAT) showed that mRNA for structural gB protein followed HSV-1 DNA titers only during primary TGs upon AMG2 treatment and generally during latent infection (p ≤ 0.05) (Figure 2D). This evidence concerns the gene LAT and disease arising from reactivation of latent virus.